#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    NTRK gene fusion overexpression Leukoencephalopathy Huntington's disease Mastocytosis Fms-like tyrosine kinase 3 positive Metastatic malignant melanoma Acute lymphocytic leukaemia Congenital hypotransferrinaemia Myasthenia gravis Neurotrophic keratopathy Hereditary hypophosphataemic rickets Paroxysmal nocturnal haemoglobinuria Pyoderma gangrenosum Thermal burn Cutaneous lupus erythematosus More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Trials in Disease Nodal marginal zone B-cell lymphoma – Basic Information Congenital hypotransferrinaemia – Diagnostics Leiomyosarcoma metastatic – Treatment Primary immunodeficiency syndrome – Trials in Disease Synovial sarcoma metastatic Fabry’s disease – Basic Information Immunodeficiency congenital Idiopathic pulmonary fibrosis – Diagnostics Mantle cell lymphoma stage IV – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Serpina1(Human)-Aav8-1 BUDOPRUTUG VX-993 Empagliflozin Mitotane Naloxone Cefuroxime Sodium Stx-241 Diphenhydramine Hydrochloride Bi 1839100 Sasanlimab GSKVX000000039711 Duloxetine SAT-3247 OXALATE Lovotibeglogene Autotemcel BNT327 Msv/As Abc-15A-116 Nedosiran Mercaptamine More therapies…

    Learn about Your Condition

    Facial paresis Haemorrhage Asymptomatic HIV infection Multiple sclerosis Diabetic nephropathy Biliary neoplasm Mesothelioma Osteonecrosis of jaw Food allergy Notalgia paraesthetica Lichen planus Insulin resistance Endometrial stromal sarcoma Thromboangiitis obliterans Left ventricular dysfunction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Phase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Epilepsy
    The Netherlands

  • Phase IIb Study of AZD8965 versus Placebo in Adults with Idiopathic Pulmonary Fibrosis

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Bulgaria Denmark France Germany Greece Hungary +4

  • Metamizole Sodium Monohydrate vs Sodium Chloride for Post‑Operative Pain Relief in Adults Undergoing Elective Laparoscopic Cholecystectomy

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Metamizole Sodium Monohydrate
    • Sodium Chloride
    Belgium

  • Dry extract from Psilocybe cubensis (15‑25:1) with methanol for adults with treatment‑resistant anorexia nervosa: a randomized, active‑placebo, triple‑blind trial

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Anorexia nervosa
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Denmark

  • Efficacy of Prednisolone Metasulfobenzoate Sodium vs Placebo in Adults with Fibrotic Hypersensitivity Pneumonitis: A Randomized Controlled Trial

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Prednisolone Metasulfobenzoate Sodium
    France

  • A double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis

    Not yet recruiting

    3 1
    Investigated Drugs:
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    • Bi 1015550
    Austria Belgium Bulgaria Croatia Czechia Denmark +15
Previous Page
1 … 669 670 671 672 673 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!